image
Healthcare - Medical - Devices - NASDAQ - US
$ 9.55
-29.3 %
$ 226 M
Market Cap
14.09
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one TCMD stock under the worst case scenario is HIDDEN Compared to the current market price of 9.55 USD, Tactile Systems Technology, Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one TCMD stock under the base case scenario is HIDDEN Compared to the current market price of 9.55 USD, Tactile Systems Technology, Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one TCMD stock under the best case scenario is HIDDEN Compared to the current market price of 9.55 USD, Tactile Systems Technology, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart TCMD

image
$20.0$20.0$18.0$18.0$16.0$16.0$14.0$14.0$12.0$12.0$10.0$10.0$8.0$8.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
293 M REVENUE
6.76%
22.2 M OPERATING INCOME
22.95%
17 M NET INCOME
-40.52%
40.7 M OPERATING CASH FLOW
13.39%
-2.5 M INVESTING CASH FLOW
-0.64%
-4.82 M FINANCING CASH FLOW
-84.19%
61.3 M REVENUE
-28.41%
-4.54 M OPERATING INCOME
-36.29%
-2.97 M NET INCOME
-30.61%
417 K OPERATING CASH FLOW
-97.45%
-407 K INVESTING CASH FLOW
17.28%
-10.8 M FINANCING CASH FLOW
-197.18%
Balance Sheet Tactile Systems Technology, Inc.
image
Current Assets 178 M
Cash & Short-Term Investments 109 M
Receivables 44.9 M
Other Current Assets 23.7 M
Non-Current Assets 120 M
Long-Term Investments 0
PP&E 22.2 M
Other Non-Current Assets 98.1 M
36.56 %15.08 %7.96 %7.46 %32.94 %Total Assets$297.9m
Current Liabilities 40.7 M
Accounts Payable 5.65 M
Short-Term Debt 2.96 M
Other Current Liabilities 32.1 M
Non-Current Liabilities 40.6 M
Long-Term Debt 23.2 M
Other Non-Current Liabilities 17.4 M
6.94 %3.63 %39.47 %28.55 %21.40 %Total Liabilities$81.3m
EFFICIENCY
Earnings Waterfall Tactile Systems Technology, Inc.
image
Revenue 293 M
Cost Of Revenue 76.3 M
Gross Profit 217 M
Operating Expenses 192 M
Operating Income 22.2 M
Other Expenses 5.22 M
Net Income 17 M
300m300m250m250m200m200m150m150m100m100m50m50m00293m(76m)217m(192m)22m(5m)17mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
73.96% GROSS MARGIN
73.96%
7.57% OPERATING MARGIN
7.57%
5.79% NET MARGIN
5.79%
7.83% ROE
7.83%
5.69% ROA
5.69%
6.16% ROIC
6.16%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Tactile Systems Technology, Inc.
image
40m40m35m35m30m30m25m25m20m20m15m15m10m10m5m5m00(5m)(5m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 17 M
Depreciation & Amortization 6.8 M
Capital Expenditures -2.51 M
Stock-Based Compensation 7.82 M
Change in Working Capital 7.71 M
Others -3.59 M
Free Cash Flow 38.1 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Tactile Systems Technology, Inc.
image
Wall Street analysts predict an average 1-year price target for TCMD of $15 , with forecasts ranging from a low of $14 to a high of $16 .
TCMD Lowest Price Target Wall Street Target
14 USD 46.60%
TCMD Average Price Target Wall Street Target
15 USD 57.07%
TCMD Highest Price Target Wall Street Target
16 USD 67.54%
Price
Max Price Target
Min Price Target
Average Price Target
20201818161614141212101088Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 15
6. Ownership
Insider Ownership Tactile Systems Technology, Inc.
image
Sold
0-3 MONTHS
810 K USD 3
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
61.9 K USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Tactile Systems Stock Tumbles As Q1 Earnings Fall Short Of Expectations Tactile Systems Technology, Inc. TCMD traded lower on Tuesday after the company's Q1 earnings missed Wall Street expectations on Monday. benzinga.com - 2 weeks ago
Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Margaret Kaczor Andrew - William Blair Ryan Zimmerman - BTIG Anderson Schock - B. Riley Securities Operator Welcome, ladies and gentlemen, to the First Quarter 2025 Earnings Conference Call for Tactile Medical. seekingalpha.com - 2 weeks ago
Tactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue Estimates Tactile Systems Technology (TCMD) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.05 per share a year ago. zacks.com - 2 weeks ago
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025. globenewswire.com - 2 weeks ago
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025 MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2025 financial results will be released after the market closes on Monday, May 5, 2025. globenewswire.com - 4 weeks ago
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which is being virtually held from March 17th – 20th. Management will participate in a virtual presentation on Tuesday, March 18th at 12:00 p.m. Eastern Time. globenewswire.com - 2 months ago
Tactile Systems Technology, Inc. (TCMD) Q4 2024 Earnings Call Transcript Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q4 2024 Earnings Conference Call February 18, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Max Smock - William Blair Adam Maeder - Piper Sandler Iseult McMahon - BTIG Kyle Bauser - B. Riley Securities Suraj Kalia - Oppenheimer & Company Operator Please standby. seekingalpha.com - 2 months ago
Tactile Systems Technology (TCMD) Tops Q4 Earnings and Revenue Estimates Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.38 per share a year ago. zacks.com - 2 months ago
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2024. globenewswire.com - 3 months ago
Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025 MINNEAPOLIS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2024 financial results will be released after the market closes on Tuesday, February 18, 2025. globenewswire.com - 3 months ago
Tactile Medical Appoints Laura King to Board of Directors MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company's Board of Directors (“Board”) and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025. globenewswire.com - 4 months ago
Is Tactile Systems Technology (TCMD) a Great Value Stock Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 4 months ago
8. Profile Summary

Tactile Systems Technology, Inc. TCMD

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 226 M
Dividend Yield 0.00%
Description Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Contact 3701 Wayzata Boulevard, Minneapolis, MN, 55416 https://www.tactilemedical.com
IPO Date July 28, 2016
Employees 1037
Officers Ms. Elaine M. Birkemeyer Chief Financial Officer Ms. Kristie T. Burns Senior Vice President of Marketing & Clinical Affairs Mr. Jerry A. Sauber Senior Vice President of Manufacturing, Operations, R&D Mr. Daniel L. Reuvers Director & Advisor Aaron R. Snodgrass Senior Vice President of Sales Ms. Sheri Louise Dodd Chief Executive Officer, President & Director Dr. Antonios P. Gasparis F.A.C.S., M.D. Chief Medical Officer & Member of Vascular Strategic Advisory Board Janelle M. Strop Chief Human Resource Officer Mr. John David Kaercher Chief Information Officer Ms. Sunday J. Hoy Esq. Vice President of Regulatory Affairs & Chief Compliance Officer